FEBO, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 193
EU - Europa 175
AS - Asia 59
AF - Africa 2
Totale 429
Nazione #
US - Stati Uniti d'America 191
IT - Italia 41
IE - Irlanda 34
SE - Svezia 34
CN - Cina 32
UA - Ucraina 19
GB - Regno Unito 14
TR - Turchia 14
FR - Francia 12
DE - Germania 6
IN - India 6
NL - Olanda 5
SG - Singapore 5
BE - Belgio 3
RU - Federazione Russa 3
CA - Canada 2
CZ - Repubblica Ceca 2
EG - Egitto 2
FI - Finlandia 2
VN - Vietnam 2
Totale 429
Città #
Chandler 56
Dublin 29
Jacksonville 24
Dearborn 15
Princeton 14
Izmir 12
Nanjing 10
Beijing 8
Southend 6
Ashburn 5
Pescara 5
Cambridge 4
Wilmington 4
Altamura 3
Ancona 3
Brussels 3
Los Angeles 3
Nanchang 3
Raleigh 3
Viterbo 3
Alexandria 2
Ann Arbor 2
Boardman 2
Brno 2
Dong Ket 2
Jinan 2
Little Rock 2
Milan 2
Rome 2
Tianjin 2
Andover 1
Asheville 1
Basciano 1
Chapel Hill 1
Chieti 1
Como 1
Edinburgh 1
Fairfield 1
Fuzhou 1
Haikou 1
Hangzhou 1
Houston 1
Isernia 1
Kocaeli 1
L'aquila 1
Lanzhou 1
Monmouth Junction 1
Montréal 1
Mumbai 1
Norwalk 1
Redwood City 1
Shenyang 1
Singapore 1
Toronto 1
Trieste 1
Trumbull 1
Washington 1
Woodbridge 1
Zhangzhou 1
Totale 262
Nome #
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment 107
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?] 83
Risk of recurrence in differentiated thyroid carcinoma one year after total thyroidectomy and radioiodine treatment 68
Serum FT3 levels and FT3/FT4 ratio as predictors for poor prognosis in hospitalized COVID-19 patients 63
Differentiated thyroid carcinoma one year after ablation 59
Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-World Setting 45
Le Magrezze 34
Totale 459
Categoria #
all - tutte 1.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 18 4 7 1 9 8 7 7 5 3 4 0
2020/202147 3 6 5 4 2 8 4 5 4 1 2 3
2021/202251 0 0 0 10 0 0 1 3 5 1 12 19
2022/2023144 13 20 9 16 15 22 4 17 15 6 2 5
2023/202447 3 2 5 0 0 12 11 0 0 4 1 9
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 459